Use of methotrexate in adult-onset Still's disease

Clinical and Experimental Rheumatology

Volumn 28, Issue 5 SUPPL. 61, 2010, Pages

  Manger, B ^a   Rech, J ^a   Schett, G ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Adult onset Still's disease; Methotrexate; Prognosis; Therapy

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD SALT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TOCILIZUMAB; ANAKINRA; CYCLOSPORIN; MYCOPHENOLATE MOFETIL;

ADULT ONSET STILL DISEASE; ARTICLE; BRAIN ABSCESS; DRUG DOSE INCREASE; DRUG FATALITY; DRUG INDICATION; DRUG INDUCED CANCER; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; INCIDENCE; INFECTION; INTERSTITIAL PNEUMONIA; KIDNEY FAILURE; LEGIONNAIRE DISEASE; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; NAUSEA; NEUTROPENIA; NOCARDIOSIS; PRIORITY JOURNAL; PROGNOSIS; RHEUMATIC DISEASE; SIDE EFFECT; SYMPTOM; UNSPECIFIED SIDE EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; HEMOPHAGOCYTIC SYNDROME; HYPERTRANSAMINASEMIA; LEGIONELLA PNEUMONITIS; LUNG HEMORRHAGE; MAXILLA TUMOR; PATHOGENESIS; PNEUMONIA; RASH; REMISSION; THROMBOCYTOPENIA;

ADULT; ANTIRHEUMATIC AGENTS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; METHOTREXATE; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 78650576885     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. BYWATERS E G L: Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.
2. YAMAGUCHI M, OHTA A, TSUNEMATSU T et al.: Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
3. FAUTREL B, ZING E, GOLMARD JL et al.: Proposal for a new set of classification criteria for adult onset Still's disease. Medicine (Baltimore) 2002;81:194-200.
4. CRISPIN JC, MARTINEZ-BANOS D, ALCOCER-VARELA J: Adult onset Still's disease as the cause of fever of unknown origin. Medicine (Baltimore) 2005;84:331-7.
5. EVENSEN KJ, NOSSENT HC: Epidemiology and outcome of adult-onset Still's disease in Northern Norway. Scand J Rheumatol 2006;35:48-51.
6. OHTA A, YAMAGUCHI M, KANEOKA H, NAGAYOSHI T, HIIDA M: Adult Still's disease: review of 228 cases from the literature. J Rheumatol 1987:14: 1139-46.
7. OHTA A, YAMAGUCHI M, TSUNEMATSU T et al.: Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990;17:1058-63.
8. POUCHOT J, SAMPALIS JS, BEAUDET F et al.: Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991:70: 118-36.
9. KRAETSCH HG, RASCU A, KALDEN JR, MANGER B: Verlauf und prognostische Parameter bei Still-Syndrom des Erwachsenen. Med Klin 1997;92:705-11.
10. AKRITIDIS N, PAPDOPOULOS A, PAPPAS G: Long-term follow-up of patients with adultonset Still's disease. Scand J Rheumatol 2006;35:395-7.
11. PAY S, TÜRKÇAPAR N, KALYONCU M et al.: A multicenter study of patients with adultonset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006;25:639-44.
12. UPPAL SS, AL-MUTAIRI M, HAYAT S, ABRAHAM M, MALAVIYA A: Ten years of clinical experience with adult onset Still's disease: Is the outcome improving? Clin Rheumatol 2007;26:1055-60.
13. SINGH S, SAMANT R, JOSHI VR: Adult onset Still's disease: a study of 14 cases. Clin Rheumatol 2008;27:35-9.
14. ZENG T, ZOU YQ, WU MF, YANG CD: Clinical features and prognosis of adult-onset Still's disease: 61 cases from China. J Rheumatol 2009;36:1026-31.
15. LEE SW, PARK YB, SONG JS, LEE SK: The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease. J Rheumatol 2009;36:156-62.
16. EFTHIMIOU P, GEORGY S: Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum 2006;36:144-52.
17. EFTHIMIOU P, PAIK PK, BIELORY L: Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.
18. FAUTREL B: Adult-onset Still disease. Best Pract Res Clin Rheum 2008;22:773-92.
19. WOUTERS JM, VAN DE PUTTE LB: Adultonset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J med 1986;61:1055-65.
20. JUNG JH, JUN JB, YOO DH et al.: High toxicity of sulfasalazine in adult-onset Still's disease. Clin Exp Rheumatol 2000;18:245-8.
21. KRAUS A, ALARCÓN-SEGOVIA D: Fever in adult onset Still's disease. Response to methotrexate. J Rheumatol 1991;18:918-20.
22. AYDINTUG AO, DCRUZ D, CERVERA R, KHAMASHTA MA, HUGHES GR: Low dose methotrexate treatment in adult Still's disease. J Rheumatol 1992;19:431-5.
23. MASSON C, LE LOËT X, LIOTÉ F et al.: Adult Still's disease. Part II. Management, outcome, and prognostic factors. Rev Rhum Engl Ed 1995;62:758-65.
24. FAUTREL B, BORGET C, ROZENBERG S et al.: Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 1999;26:373-8.
25. FUJII T, AKIZUK! M, KAMEDA H et al.: Methotrexate treatment in patients with adult onset Still's disease - retrospective study of 13 Japanese cases. Ann Rheum Dis 1997;56:144-8.
26. SAMUELS AJ, BERNEY SN, TOURTELLOTTE CD, ARTYMYSHYN R: Coexistence of adult onset Still's disease and polymyositis with rhabdomyolysis successfully treated with methotrexate and corticosteroids. J Rheumatol 1989;16:685-7.
27. BARBADILLO C, CUENDE E, MAZZUC-CHELLI R, MULERO J, ANDREU-SÁNCHEZ JL: Still's disease in adults and polymyositis. An infrequent association. Med Clin (Barc) 1992;99:382-3.
28. YAMAGUCHI M, MATSUKAWA Y, TAKAHASHI N et al.: Successful methotrexate therapy for adult Still's disease with marked thrombocytopenia. Clin Rheumatol 1998;17:256-7.
29. OKAMOTO O, OISHI M, FUJIWARA S: Steroid-resistant adult-onset Still's disease, which showed a quick response to methotrexate. J Dermatol 2008;35:106-10.
30. VILÁ LM, MOLINA MJ: Chronic anemia and thrombocytosis as the initial presentation of Still's disease in an elderly patient. Gerontology 2007;53:289-92.
31. KURASAWA M, KOTANI K, KURASAWA G, SHIDA K, YAMADA S, TAGO T: Adult-onset Still's disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy. Age Ageing 2007;36:104-6.
32. SARI I, BIRLIK M, BINICIER O et al.: A case of adult-onset Still's disease complicated with diffuse alveolar hemorrhage. J Korean Med Sci 2009;24:155-7.
33. ARLET JB, LE TH, MARINHO A et al.: Reactive haemophagocytic syndrome in adultonset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 2006;65:1596-601.
34. HOT A, TOH ML, COPPÉRÉ B et al.: Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine (Baltimore) 2010;89:37-46.
35. MICHEL M, HAYEM G, RAT AC et al.: Complcations infectieuses fatales chez deux patients atteints de maladie de Still de l'adulte. Rev Méd Interne 1996;17:407-9.
36. TANAKA A, SHIGEMATSU H, KOJIMA M, SAKASHITA H, KUSAMA K: Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still's disease. J Oral Maxillofac Surg 2008;66:1492-5.
37. DECHANT C, SCHULZE-KOOPS H: Adulter Morbus Still. Akt Rheumatol 2008;33:108-14.
38. KÖTTER I, WACKER A, KOCH S et al.: Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 2007;37:189-97.
39. EFTHIMIOU P, KONTZIAS A, WARD CM, OGDEN NS: Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nature Clin Pract Rheum 2007;3:328-335.
40. SEGAL R, MOZES E, YARON M, TARTAKOVSKY B: The effects of methotrexate on the production and activity of interleukin-l. Arthritis Rheum 1989;32:370-7.
41. CHANG DM, WEINBLATT ME, SCHUR PH: The effects of methotrexate on interleukin-l in patients with rheumatoid arthritis. J Rheumatol 1992;19:1678-82.
42. THOMAS R, CARROLL GJ: Reduction of leukocyte and interleukin-l beta concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1993;36:1244-52.
43. BARRERA P, BOERBOOMS A M T, DEMACKER P N M, VAN DE PUTTE L B A, GALLATI H, VAN DER MEER J W M: Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effects of a single dose methotrexate. Br J Rheumatol 1994;33:1017-24.